Safety and Efficacy of Abatacept in IgG4-Related Disease
Clinical trial NCT03669861 · COMPLETED
Trial details
- NCT number
- NCT03669861
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-13
- Primary completion
- 2020-04-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.